LOS ANGELES, July 28, 2009 (GLOBE NEWSWIRE) -- Universal Detection Technology (www.udetection.com) (OTCBB:UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it has been granted a patent from the U.S. Patent and Trademark Office (USPTO) for its automated airborne anthrax detection system. The patent is the company's second for technology licensed by the California Institute of Technology (Caltech).
Titled "Apparatus and Method for Automated Monitoring of Bacterial Spores," the invention has been filed under USPTO number US 7,563,615 B2 and describes an apparatus and method for automated monitoring of airborne bacterial spores.
"Universal Detection Technology's second patent on its licensed technology is another step forward in providing critical counter-bioterrorism equipment to organizations in the public, commercial and private sectors," said Universal Detection Technology CEO Jacques Tizabi. "This distinction will allow us to continue to bolster our intellectual property rights in the U.S. and abroad."
The granted patent supplements the patent granted to the company in 2007 by providing intellectual property rights for the automated detection of airborne bacterial spores. Universal Detection Technology's BSM-2000 utilizes both technologies in its monitoring of airborne hazards.
The apparatus is provided with an air sampler, a surface for capturing bacterial spores, a source of lanthanide ions, and a spectrometer for excitation and detection of the characteristic fluorescence of the aromatic molecules in bacterial spores complexed with lanthanide ions. In accordance with the method, computer-programmed steps allow for automation of the apparatus for the monitoring of airborne bacterial spores.
For more information please visit www.udetection.com or email info@udetection.com
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com.
The Universal Detection Technology logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4911
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.